Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study

被引：36

作者：

Albiges, L. ^{[1
]}

Rini, B. I. ^{[2
]}

Peltola, K. ^{[3
]}

Oria, G. A. De Velasco ^{[4
]}

Burotto, M. ^{[5
]}

Rodriguez, C. Suarez ^{[6
]}

Ghatalia, P. ^{[7
]}

Iacovelli, R. ^{[8
]}

Lam, E. T. ^{[9
]}

Verzoni, E. ^{[10
]}

Gumus, M. ^{[11
]}

Stadler, W. M. ^{[12
]}

Kollmannsberger, C. K. ^{[13
]}

Melichar, B. ^{[14
]}

Venugopal, B. ^{[15
]}

Wang, A. ^{[16
]}

Perini, R. ^{[17
]}

Vickery, D. ^{[18
]}

Powles, T. B. ^{[19
]}

Choueiri, T. K. ^{[20
]}

机构：

[1] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[2] Vanderbilt Ingram Canc Ctr, Dept Oncol, Nashville, OH USA

[3] Univ Helsinki, Clin Trial Unit, Comprehens Canc Ctr, Cent Hosp, Helsinki, Finland

[4] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain

[5] Bradford Hill Clin Ctr, Oncol, Santiago, Chile

[6] Vall dHebron Univ Hosp, Dept Oncol, Barcelona, Spain

[7] Fox Chase Canc Ctr, Med Oncol, Main Campus, Philadelphia, PA USA

[8] Fdn Policlin Univ Agostino Gemelli IRCCS, Med Oncol, Rome, Italy

[9] Univ Colorado, Internal Med, Med Oncol, UCHealth Canc Care,Canc Ctr, Anschutz Med Campus, Aurora, CO USA

[10] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[11] Istanbul Medeniyet Univ, Prof Dr Suleyman Yalcin City Hosp, Dept Med Oncol, Istanbul, Turkiye

[12] Univ Chicago, Ctr Canc, Med Ctr, Chicago, IL USA

[13] BC Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada

[14] Univ Hosp Olomouc, Dept Oncol, FN Olomouc, Olomouc, Czech Republic

[15] NHS Greater Glasgow & Clyde, Dept Med Oncol, BWSCC Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[16] Merck & Co Inc, Biostat, Rahway, NJ USA

[17] Merck & Co Inc, Dept Oncol, Corp Headquarters, Whitehouse Stn, NJ USA

[18] Merck & Co Inc Rahway, Oncol Clin Dev, Rahway, NJ USA

[19] St Bartholomews Hosp Barts Hlth NHS Trust, Dept Oncol, London, England

[20] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.090

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA88

引用

页码：S1329 / S1330

页数：3